INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1219551222-Patient-Person-Recruitment-Select]( "Merits Of A Multifaceted Approach To Clinical Trial Recruitment")
Merits Of A Multifaceted Approach To Clinical Trial RecruitmentThe best way to address clinical trial recruitment challenges is with a multifaceted approach that goes beyond traditional channels and ways of thinking.
-
![GettyImages-1719538555 in home nurse visit patient]( "Improving Patient Access Through Home-Based Trials, Site Networks")
Improving Patient Access Through Home-Based Trials, Site NetworksBy implementing home trial support, sponsors can improve patient access, enhance diversity, and ultimately accelerate the development of new therapies.
-
![GettyImages-2154375908-doctor-patient-office-handshake]( "How The Right Meetings Make Patient-Centered Trial Design Possible")
How The Right Meetings Make Patient-Centered Trial Design PossibleIncluding patients in trial design improves recruitment, retention, and site experience. Explore practical ways sponsors can gather early input—without disrupting timelines or adding complexity.
-
![GettyImages-1349441051 drugs]( "Drug-Drug Interaction Study On A Novel Cardiovascular Medication")
Drug-Drug Interaction Study On A Novel Cardiovascular MedicationLearn how Altasciences leveraged its expertise to design, recruit, and conduct complex DDI studies, assessing pharmacokinetic and pharmacodynamic impacts of co-administered drugs.
-
Linking Neurology And Ophthalmology For Clinical Trials1/22/2025
Learn more about the innovative approach being taken to incorporate ophthalmology into neurology and central nervous system (CNS) research.
-
Anthropic's Stainless Acquisition: What It Means For Clinical Trials6/5/2026
As AI models become interchangeable, value is shifting to the orchestration layer that connects tools, workflows, and governance—making flexibility, interoperability, and auditability critical.
-
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs2/20/2025
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
The Future Of Patient Participation In Clinical Research2/18/2025
To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.
-
Advancing Dose Escalation Strategies With Bayesian Modeling8/12/2025
A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1132766141 patient recruitment]( "A New Blueprint For Transforming Feasibility And Recruitment")
Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
-
![microplate panel for diseases diagnosis GettyImages-1387090964]( "Bringing Endocrine And Metabolic Disease Treatments To Market")
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
-
![getty-1311598658-data-analytics]( "Optimize And Expedite Clinical Trial Design, Planning, and Execution")
Obtain smarter, faster, and more resilient clinical trials that reduce cost, improve outcomes, and bring life-changing therapies to patients sooner with integrated, user-friendly technology.
-
![GettyImages-1358835459-computer-gear-digital-hands]( "Elosity: Next-Generation RTSM")
With its agile, user-centric approach, Elosity empowers sponsors, sites, and operational teams to manage clinical programs on their terms while meeting the demands of modern clinical research.
-
![Cloud computing digita-GettyImages-2161057424]( "Unify Workflows And Accelerate Execution From Protocol To Submission")
Explore a platform that benefits the entire global clinical trial ecosystem by reducing complexity and operational costs while maintaining the highest standards of data security and subject privacy.
